15 CUSHING, IRVINE, CA
Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
Shareholders Approve Amendment to 2018 Equity Incentive Plan
Amended material disclosure
Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
Annual Report to Security Holders
News, Articles of Incorporation
Financial Results, Press Release
Insight Molecular Diagnostics Enters Specimen Collection Agreement with Quest...
Q2
Q1
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Notice of Exempt Offering of Securities
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Correspondence
Submission Upload